Send the following on WhatsApp
Continue to Chathttps://es.marketscreener.com/cotizacion/accion/ARAVIVE-INC-46676792/noticia/Aravive-Inc-anuncia-el-dise-o-del-ensayo-de-fase-3-de-batiraxcept-en-carcinoma-de-celulas-renale-43873800/?utm_source=whatsapp&utm_medium=social&utm_campaign=share